NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/13/2023
Back to search
Official data from USPTO
SAREPTALLY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/13/2023
Trademark type
Combined
Nice classes
42, 44
Filing date
05/26/2021
Registration date
06/13/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2023
Last transaction
06/13/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/15/2022
First use in commerce
06/15/2022
Drawing code
3
Owner type
03
Owner location
Cambridge, MA, US
Examiner
BECHHOFER, YOCHEVED D
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term SAREPTALLY beneath a stylized sphere design consisting of four sections.
Holders and representatives
Holders
Sarepta Therapeutics, Inc.
Representatives
Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing information about medical and healthcare research and clinical trials; providing information to healthcare providers and patients about medical and healthcare research and clinical trials
Class 44
Providing prescription pharmaceuticals through early access pathways in the nature of a patient assistance program to provide drugs to eligible patients; providing information about access to medical treatments and services; counselling servicesproviding information and counselling with respect to access to medical treatment and care; providing health information; Providing access to pharmaceuticals in the nature of a patient assistance program to provide drugs to eligible patients; providing information to healthcare providers and patients about medicationaccess to medical treatment and carelocal pathways for access to medical treatment and care
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/12/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/05/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/04/2023
EX1G
SOU EXTENSION 1 GRANTED
05/04/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/03/2023
IUAF
USE AMENDMENT FILED
04/17/2023
EXT1
SOU EXTENSION 1 FILED
04/17/2023
EISU
TEAS STATEMENT OF USE RECEIVED
04/17/2023
EEXT
SOU TEAS EXTENSION RECEIVED
04/14/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/13/2022
PUBO
PUBLISHED FOR OPPOSITION
09/13/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/24/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/29/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/28/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/28/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/07/2022
GNRT
NON-FINAL ACTION E-MAILED
02/07/2022
CNRT
NON-FINAL ACTION WRITTEN
02/07/2022
DOCK
ASSIGNED TO EXAMINER
02/02/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/21/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/20/2021
NWAP
NEW APPLICATION ENTERED
05/29/2021
Continuous trademark protection
Get notified about every new filing that threatens SAREPTALLY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.